Maha Othman – ”BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!”
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network, shared on LinkedIn:
”Just returned from my first BIC – and what an experience!
A niche and well-organized conference, BIC 2025 brought together cutting-edge science, rich discussions, and an inspiring community of experts — all set in the beautiful city of Padua.
I had the opportunity to present novel AI-driven data on G14, a potent peptide inhibitor that disrupts the Platelet–VWF interaction.
This research has promising diagnostic and therapeutic potential in PT-VWD and Type 2B VWD; two bleeding disorders.
Proud to share that this collaborative work — between my lab at Queen’s University ’, Thomas Kazmirchuk, Ashkan Golshani Lab at Carleton University — has just been published in Blood Advances.
It was also a pleasure catching up with so many respected colleagues mentors and brilliant minds in the field — Glenn F. Pierce, David Lillicrap, Bernhard Lämmle, Augusto Federici, Cécile Denis, Caterina Casari, Edward Tuddenham, Wolfgang Miesbach …many others and meet rising stars/ make new friends like Gregory Newby, Alexander Tischer and Mathew Auton.
Akso got a chance to see/ experience a glimpse of the fascinating Italian culture , food and architecture Venice, Padua
A special thanks to Flora Peyvandi for decades of research and leadership in this field, and to the BIC organizing committee for the kind invitation.
Always grateful to St. Lawrence College for supporting professional development and quality research.
Thanks to all my students waiting for me to come back to resume our teaching / learning journey and career building!
BIC 2025 is without a doubt a remarkable scientific event — and I’m excited for what lies ahead!”
More from BIC 2025 featured in Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge